CX-02 (Cantex)

N/A

Report date: 2025/06/11 20:01:15
NME

Base Information

Drug NameCX-02 (Cantex)
Drug Alias NameN/A
ClassificationSmall molecules > Carbohydrate > Oligosaccharide
Mechanisms of ActionComplement system proteins inhibitorsLeukocyte elastase inhibitorsHeparin agonists +[6] 
TargetsLeukocyte adhesion molecule-1HeparinCathepsin G +[6] 
Therapy Area/IndicationsRadiation sicknessProstatic NeoplasmsBreast Neoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesCantex Pharmaceuticals Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesNational Institutes Of HealthCantex Pharmaceuticals Inc
Active IndicationsN/A
Inactive IndicationsRadiation sicknessProstatic NeoplasmsBreast Neoplasms

Other Information

ATC CodeN/A
Related LinksN/A